Vimarsana
Biggest News Aggregation in the World

Page 2 - Products Grants Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Products Grants Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Products Grants Program Today - Breaking & Trending Today

$38 million will fund rare disease research over four-year period - Vimarsana News

$38 million will fund rare disease research over four-year period

Research for rare diseases including ALS will be supported over the next four years by $38 million in FDA funding.

FDA Awards Above $38 Mln Worth Grants, Contracts In Rare Diseases - Vimarsana News

FDA Awards Above $38 Mln Worth Grants, Contracts In Rare Diseases

WASHINGTON (dpa-AFX) - The U.S. Food and Drug Administration has awarded 19 new grants and two new contracts totaling more than $38 million in funding mainly to develop medical products to treat

FDA Awards 19 Grants and Two Contracts Related to Rare Diseases, including ALS - Vimarsana News

FDA Awards 19 Grants and Two Contracts Related to Rare Diseases, including ALS

/PRNewswire/ -- Today, the U.S. Food and Drug Administration announced it has awarded 19 new grants and two new contracts totaling more than $38 million in...

FDA Oks Bristol Myers' Orencia To Prevent Graft Versus Host Disease - Vimarsana News

FDA Oks Bristol Myers' Orencia To Prevent Graft Versus Host Disease

NEW YORK CITY (dpa-AFX) - Bristol Myers Squibb's Orencia has received approval from the U.S. Food and Drug Administration for prophylaxis or prevention of acute graft versus host disease or aGVHD.This

FDA Approves First Drug to Prevent Graft Versus Host Disease - Vimarsana News

FDA Approves First Drug to Prevent Graft Versus Host Disease

/PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Orencia (abatacept) for the prophylaxis (prevention) of acute graft versus host disease...